scispace - formally typeset
A

Alfredo Madrid García

Researcher at Hospital Clínico San Carlos

Publications -  15
Citations -  123

Alfredo Madrid García is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 5 publications receiving 60 citations.

Papers
More filters
Journal ArticleDOI

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.

TL;DR: It is suggested that age and having a systemic autoimmune condition increased the risk of hospital admission, whereas disease-modifying antirheumatic drugs were not associated with hospital admission.
Journal ArticleDOI

Sat0557 outpatient readmission in rheumatology: a machine learning predictive model of patient’s return to the clinic

TL;DR: A predictive model for outpatient readmission in a rheumatology setting based on Random Forest was developed and validated, and the most relevant variables in the model were the number of diagnoses given at discharge, follow-up duration, age, number of previous discharges, previous corticosteroids use and disability.
Posted ContentDOI

Post discharge persistent symptoms after COVID-19 in rheumatic and musculoskeletal diseases

TL;DR: In this article, the authors performed a cross-sectional observational study to describe persistent symptoms and consequences in Rheumatic and Musculoskeletal diseases (RMD) discharged from the hospital after Covid-19.
Proceedings ArticleDOI

Ab0748 evolution on health-related quality of life in psoriatic arthritis patients

TL;DR: Different factors associated with HRQoL during the evolution of patients with PsA are identified, including the presence of certain comorbidities were independently associated with a worse HRZoL and the use of methotrexate and bone-forming agents were independentlyassociated with a better HRQeL.
Journal ArticleDOI

Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops et al .

TL;DR: This study is a real-world longitudinal study performed during the period of maximum health emergency due to the COVID-19 pandemic in Madrid, the epicentre of the outbreak in Spain, and provides additional evidence in patients with IRD regarding susceptibility to moderate-severe infection related to CO VID-19.